NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
02/24/2022
Back to search
Official data from USPTO
ISOGENICA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ISOGENICA
ST13
US500000079084070Class
5, 42, 45
Filing
79084070
Registration
3980235
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
02/24/2022
Trademark type
Word
Nice classes
5, 42, 45
Filing date
01/22/2010
Registration date
06/21/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/24/2022
Last transaction
02/24/2022
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Cambridgeshire, GB
Examiner
HAYES, GINA
Law office
L30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Isogenica Ltd
Representatives
Steven M. Espenshade Pirkey Barber PLLC
Technical classification
Nice Classes
Class 5Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic and therapeutic synthetic peptidesproteinsmoleculesantibodiespolypeptides and polymers for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; diagnostic preparations for medical use; pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders
Class 42
Scientificpharmaceuticalmedicalbiologicalbiochemicalbiotechnology and diagnostic research in the field of in-vitro screening and protein engineering; biochemical research and development; biotechnological engineeringthe engineering of peptidesproteinsmoleculesantibodiespolypeptides and polymers
Class 45
Licensing of intellectual property; licensing of technology in the field of in-vitro screening and protein engineering relating to discovery of peptides for therapeutic and non-therapeutic applications
Publications
History of USPTO decisions and trademark events.
46 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
02/24/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/15/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/13/2021
ES71
TEAS SECTION 71 RECEIVED
06/21/2021
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
06/21/2020
RNWL
INTERNATIONAL REGISTRATION RENEWED
02/06/2020
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
12/08/2017
71AG
REGISTERED-SEC.71 ACCEPTED
12/08/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/06/2017
ES71
TEAS SECTION 71 RECEIVED
11/13/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/19/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/13/2015
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/03/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/17/2011
FIMP
FINAL DISPOSITION PROCESSED
11/17/2011
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/21/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
06/21/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/05/2011
PUBO
PUBLISHED FOR OPPOSITION
04/05/2011
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/17/2011
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/17/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/25/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/25/2011
XAEC
EXAMINER'S AMENDMENT ENTERED
02/24/2011
ALIE
ASSIGNED TO LIE
02/24/2011
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/24/2011
GNEA
EXAMINERS AMENDMENT E-MAILED
02/24/2011
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/24/2011
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/18/2011
GNFR
FINAL REFUSAL E-MAILED
02/18/2011
CNFR
FINAL REFUSAL WRITTEN
02/18/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/27/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/26/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/26/2011
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/08/2010
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/08/2010
RFNP
REFUSAL PROCESSED BY IB
08/28/2010
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/28/2010
RFRR
REFUSAL PROCESSED BY MPU
07/28/2010
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/28/2010
CNRT
NON-FINAL ACTION WRITTEN
07/27/2010
MAFR
APPLICATION FILING RECEIPT MAILED
07/27/2010
DOCK
ASSIGNED TO EXAMINER
07/23/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/23/2010
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/22/2010
Continuous trademark protection
Get notified about every new filing that threatens ISOGENICA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.